close 76% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 76% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Dashboard

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Strona główna・Stock List・Jazz Pharmaceuticals PLC
Search

Jazz Pharmaceuticals PLC

Closed

SectorHealthcare

108.34 -1.69

Strong Buy

Price update 13 cze 2025, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

107.79

Max

109.6

Key metrics

By Trading Economics

Income

-284M

-93M

Sales

-190M

898M

P/E

Sector Avg

15.2

51.748

EPS

1.68

Profit margin

-10.307

Employees

2,800

EBITDA

-275M

109M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+68.41% upside

Dividends

By Dow Jones

Next Earnings

30 lip 2025

Market Stats

By TradingEconomics

Market Cap

-504M

6.9B

Previous open

110.03

Previous close

108.34

News Sentiment

By Acuity

50%

50%

177 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 111.22 Support & Resistance

Jazz Pharmaceuticals PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

DJ

Read

31 paź 2024, 15:29 UTC

Major Market Movers

Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation

DJ

Read

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

68.41% upside

12 Months Forecast

Average 182.73 USD  68.41%

High 230 USD

Low 147 USD

Based on 14 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

13

Buy

1

Hold

0

Sell

Based on 14 analysts giving stock ratings to Jazz Pharmaceuticals PLC - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 111.22Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

177 / 380 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

818.58

↑ +0.92%

JNJ

Johnson and Johnson

156.9

↑ +0.22%

ABBV

AbbVie Inc

190.58

↓-0.85%

NVO

Novo Nordisk A-S

79.74

↓-1.64%

UNH

UnitedHealth Group Inc

313.25

↓-1.52%